‘Storm Of Change’ Could Propel Industry On Making Daily Oral Contraceptive Available OTC In US

“It’s going to be industry people like me that have to make a decision that we're going to spend the time, we're going to spend the money to work with FDA for the many years it takes generally speaking to get these things approved,” says Femasys CEO Kathy Lee-Sepsick.

• Source: Shutterstock

The chief executive of a woman’s reproductive health technology developer suggests pharma and medtech firms ask why an oral daily contraceptive isn’t already available OTC in the US, and answer by taking responsibility to make it happen.

“We all could probably agree that women understand how to use their birth control pills, they've had access to them for decades

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation